Gilead Sciences Inc. (GILD): Price and Financial Metrics

GILD POWR Grades

• Value is the dimension where GILD ranks best; there it ranks ahead of 96.18% of US stocks.
• The strongest trend for GILD is in Growth, which has been heading up over the past 177 days.
• GILD's current lowest rank is in the Momentum metric (where it is better than 4.01% of US stocks).

GILD Stock Summary

• GILD has a higher market value than 97.69% of US stocks; more precisely, its current market capitalization is $94,599,500,668.
• GILD's went public 31.83 years ago, making it older than 83.17% of listed US stocks we're tracking.
• In terms of volatility of its share price, GILD is more volatile than merely 1.12% of stocks we're observing.
• Stocks that are quantitatively similar to GILD, based on their financial statements, market capitalization, and price volatility, are NTES, ADI, TXN, PYPL, and BMY.
• Visit GILD's SEC page to see the company's official filings. To visit the company's web site, go to www.gilead.com.

GILD Valuation Summary

• GILD's price/earnings ratio is 18.5; this is 23.87% lower than that of the median Healthcare stock.
• Over the past 243 months, GILD's price/sales ratio has gone down 11.7.

Below are key valuation metrics over time for GILD.

GILD Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -60.73%.
• Its 5 year net cashflow from operations growth rate is now at -41.74%.
• The 5 year net income to common stockholders growth rate now stands at -60.73%.

Over the past 34 months, GILD's revenue has gone up $4,565,000,000.

The table below shows GILD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	27,281	9,072	4,592
2022-09-30	27,136	9,710	3,334
2022-06-30	27,515	10,100	4,137
2022-03-31	27,472	10,614	4,515
2021-12-31	27,305	11,384	6,225
2021-09-30	27,482	10,095	7,394

GILD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• GILD has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• GILD's asset turnover comes in at 0.406 -- ranking 114th of 682 Pharmaceutical Products stocks.
• ENTA, RDUS, and ADMS are the stocks whose asset turnover ratios are most correlated with GILD.

The table below shows GILD's key quality metrics over time.